What can a row settle to?
Column three takes one of five values, never a sixth: an approved label noted in the pack, a human interventional record, a review, a registered study with no result, or nothing. All five appear in the table today. A supplier document isn't one of the five, which is why the supplier's lot has its own table on one lot, one certificate identifier.
How do we write the narrow version?
We write column two from the record, then cut one word at a time until cutting more would make it false. It never carries an amount, unit, frequency or route. If a cell can't be cut to something true, the row goes back for more work.
Why keep a row that says "Nothing"?
Because it's the most useful row in the table. It tells you plainly that a claim you heard has no record here. A missing row looks like an oversight. A published "Nothing" is a finding.
How are rows sorted, and how do we fix mistakes?
Rows sort on column three: an approved label, a human trial record, a review, a registered study with no result, then nothing. Within each group, more common claims come first. The order is fixed. A correction goes to the row it fixes, and the read date moves with it. The table itself is on the scope table.
Where did our sources come from?
The strongest evidence in our sources is a human randomized controlled trial, so nothing here claims more than that. We pulled our sources from NCBI E-utilities and the ClinicalTrials.gov v2 API on 2026-09-05. Every address we cite answered. We wrote each profile from those abstracts alone, and a separate model checked every claim against its abstract. Amounts, frequencies, durations and routes were left out at every step.
About the supplier we name
What is Peptara Labs, and what does it publish?
Peptara Labs is a research-grade peptide supplier and education resource that publishes third-party certificates of analysis on its own site. It lists sixteen research-grade products, including this one. We name it because its lot for this compound is the one we show.
Who tests the peptides Peptara Labs sells?
Titreon Analytical, described on the live page as a third-party laboratory whose quality system is aligned to ISO/IEC 17025:2017, not itself accredited. We always keep that qualifier with the name. A quality system aligned to a standard is not the same as holding it.
Is Peptara Labs the source of an approved PT-141 product?
No. Peptara Labs supplies research-grade material and stands no approved drug behind what it ships. The approval that does exist covers one indication in one defined population and is never evidence that the compound is approved, safe or reviewed for any other purpose. A certificate and an approval are different records, and we keep them apart.
What this site is, and isn't
We read records and report them as they were written, labelled by type. Supplier documents are reported in their own terms. Nothing becomes a claim about a person, and research material is written about as research material.
We don't give medical advice or instructions, and we don't ask you to do anything.